🔎 Trials Near Me

Avaleht › Skisofreenia › Florida

Skisofreenia kliinilised uuringud osariigis Florida

26 uuringut haiguse Skisofreenia jaoks otsivad osalejaid osariigis Florida.

Linnad osariigis Florida

Ametlik uuringutekst (inglise keeles)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Local Institution - 0019, Miami
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07101094

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  • Research Centers of America ( Hollywood ), Hollywood
  • Local Institution - 0195, Oakland Park
  • Health Synergy Clinical Research, West Palm Beach
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 28. sept 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Sarkis Clinical Trials, Gainesville
  • United Research Institute, Hialeah
  • Advanced Research Institute of Miami, Homestead
  • ja veel 13
VärbamineFaas 3
Vanused 5–17 · Kõik sood · Uuendatud 25. sept 2026 · NCT06229210

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07105098

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Site, Atlantis
  • Neurocrine Clinical Site, Aventura
  • Neurocrine Clinical Site, Hollywood
  • ja veel 5
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Maitland
  • Neurocrine Clinical Site, Miami
  • ja veel 3
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0145, Boca Raton
  • Local Institution - 0160, Gainesville
  • Local Institution - 0164, Gainesville
  • ja veel 2
VärbamineFaas 3
Vanused 5–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Magno Medical Research Group, Cooper City
  • NextPhase Research Florida - Hollywood, Hollywood
  • Innovative Clinical Research, Lauderhill
  • ja veel 5
VärbamineFaas 2
Vanused 18–55 · Kõik sood · Uuendatud 22. sept 2026 · NCT07410507

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Bonita Springs
  • Neurocrine Clinical Site, Hialeah
  • Neurocrine Clinical Site, Miami
  • ja veel 3
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. sept 2026 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

  • University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - DeLand Clinical Research Unit, DeLand
  • Behavioral Clinical Research, Inc., Hollywood
  • CenExel Hollywood FL, Hollywood
  • ja veel 1
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 17. sept 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

  • CenExel, Hollywood
  • Segal Trials, Miami Lakes
  • Health Synergy Clinical Research, West Palm Beach
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 9. sept 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • Local Institution - 0119, Hollywood
  • Apg Research, Llc, Orlando
VärbamineFaas 3
Vanused 13–17 · Kõik sood · Uuendatud 4. sept 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

  • Research Centers of America ( Hollywood ), Hollywood
  • Innovative Clinical Research, Inc., Miami Lakes
VärbamineFaas 1
Vanused 18–55 · Kõik sood · Uuendatud 2. sept 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Hollywood
  • Clinical Site, Hollywood
  • Clinical Site, Miami
  • ja veel 2
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 1. sept 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Envision Trials LLC, Bonita Springs
  • Galiz Research, Hialeah
  • Local Institution - 0030, Homestead
  • ja veel 7
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, Miami Lakes
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 14. aug 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

  • Bioxcel Clinical Research Site, Hialeah
VärbamineFaas 1
Vanused 10–17 · Kõik sood · Uuendatud 11. aug 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

  • Segal Institute for Clinical Research, Miami
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 29. juuli 2026 · NCT07467993

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

  • Health Synergy Clinical Research, Boynton Beach
  • Innovative Clinical Research, Miami Lakes
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 27. juuli 2026 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

  • NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach
  • Cenexel RCA, Hollywood
VärbamineFaas 2
Vanused 18–55 · Kõik sood · Uuendatud 23. juuni 2026 · NCT07191483

A Study to Evaluate the Effect of KarXT on Urological Safety

  • Innovative Clinical Research, Lauderhill
  • Health Synergy Clinical Research, West Palm Beach
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 3. juuni 2026 · NCT07221877

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Hollywood
  • Neurocrine Clinical Site, Miami Lakes
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 6. märts 2026 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

  • University of Miami, Miami
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 23. jaan 2026 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

  • Vanda Investigational Site, North Miami
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 12. jaan 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

  • Site 5060, Hollywood
  • Site 5015, Tampa
VärbamineFaas 2
Vanused 21–55 · Kõik sood · Uuendatud 26. dets 2025 · NCT06502964

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • Reviva site, Hollywood
  • Reviva site, Hollywood
  • Reviva site, Miami Lakes
VärbamineFaas 3Terved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 19. dets 2024 · NCT05184335

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.